- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of invasive meningococcal diseases (IMDs)
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 390KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 56KB)
Meningococcal vaccine – November 2023
Meningococcal vaccine: Injection 0.5 mL; Menveo®
Last updated
1 March 2024